Glucovance generics launch
Executive Summary
Ivax launches its generic version of Bristol-Myers Squibb's Glucovance (glyburide/ metformin) May 4, triggering 180 days of marketing exclusivity. Par entered the market with an "authorized" generic the same day. Ivax has been building inventory since ANDA approval Feb. 18 (1"The Pink Sheet" Feb. 23, 2004, In Brief)...